Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Paddy Clanwilliam resigns from Angus Energy board

(Sharecast News) - Angus Energy announced the resignation of Patrick 'Paddy' Clanwilliam from his position as non-executive chairman on Friday. The AIM-traded firm said Clanwilliam joined the board in 2019 and had served as interim chair since August last year.

"We are very grateful to Paddy for his leadership and wise counsel during the five years of his involvement with Angus Energy," said chief executive officer Richard Herbert.

"As chairman, he was closely involved in the successful redevelopment of the Saltfleetby gas field, and in the subsequent refinancing of the company, putting Angus Energy on a secure financial footing to commence the next stage of the company's development.

"Paddy had stated his intention to step down at the conclusion of the refinancing project, which was announced last month."

In light of Clanwilliam's resignation, the board had appointed Krzysztof Zielicki, currently a non-executive director, to serve as the interim chair until a permanent successor was selected.

At 1354 GMT, shares in Angus Energy were up 6.67% at 0.4p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Goldman Sachs downgrades SSP to 'sell', prefers WH Smith
(Sharecast News) - Goldman Sachs downgraded SSP on Monday to 'sell' from 'neutral' "on a relative basis" as it took a look at European travel concessions.
UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.